NantHealth Competitors

NantHealth (NASDAQ:NH) and Cars.com (NYSE:CARS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation and risk.

Valuation & Earnings

This table compares NantHealth and Cars.com's gross revenue, earnings per share and valuation.

NantHealth has higher earnings, but lower revenue than Cars.com. NantHealth is trading at a lower price-to-earnings ratio than Cars.com, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

NantHealth has a beta of 1.83, indicating that its share price is 83% more volatile than the S&P 500. Comparatively, Cars.com has a beta of 2.41, indicating that its share price is 141% more volatile than the S&P 500.

Profitability

This table compares NantHealth and Cars.com's net margins, return on equity and return on assets.

Institutional and Insider Ownership

5.5% of NantHealth shares are owned by institutional investors. Comparatively, 95.6% of Cars.com shares are owned by institutional investors. 59.6% of NantHealth shares are owned by insiders. Comparatively, 0.5% of Cars.com shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and price targets for NantHealth and Cars.com, as provided by MarketBeat.

Cars.com has a consensus price target of $14.00, indicating a potential upside of 4.32%. Given Cars.com's higher probable upside, analysts clearly believe Cars.com is more favorable than NantHealth.

Summary

Cars.com beats NantHealth on 9 of the 13 factors compared between the two stocks.

NantHealth (NASDAQ:NH) and So-Young International (NASDAQ:SY) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation and risk.

Analyst Ratings

This is a summary of recent ratings and price targets for NantHealth and So-Young International, as provided by MarketBeat.

So-Young International has a consensus price target of $14.00, indicating a potential upside of 63.55%. Given So-Young International's higher probable upside, analysts clearly believe So-Young International is more favorable than NantHealth.

Risk and Volatility

NantHealth has a beta of 1.83, indicating that its share price is 83% more volatile than the S&P 500. Comparatively, So-Young International has a beta of 0.35, indicating that its share price is 65% less volatile than the S&P 500.

Valuation & Earnings

This table compares NantHealth and So-Young International's gross revenue, earnings per share and valuation.

So-Young International has higher revenue and earnings than NantHealth.

Profitability

This table compares NantHealth and So-Young International's net margins, return on equity and return on assets.

Institutional and Insider Ownership

5.5% of NantHealth shares are owned by institutional investors. Comparatively, 27.4% of So-Young International shares are owned by institutional investors. 59.6% of NantHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

So-Young International beats NantHealth on 10 of the 12 factors compared between the two stocks.

Tucows (NASDAQ:TCX) and NantHealth (NASDAQ:NH) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

Institutional & Insider Ownership

56.4% of Tucows shares are owned by institutional investors. Comparatively, 5.5% of NantHealth shares are owned by institutional investors. 13.5% of Tucows shares are owned by company insiders. Comparatively, 59.6% of NantHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Tucows and NantHealth's net margins, return on equity and return on assets.

Risk and Volatility

Tucows has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500. Comparatively, NantHealth has a beta of 1.83, suggesting that its stock price is 83% more volatile than the S&P 500.

Valuation & Earnings

This table compares Tucows and NantHealth's revenue, earnings per share and valuation.

Tucows has higher revenue and earnings than NantHealth.

Analyst Recommendations

This is a breakdown of current ratings for Tucows and NantHealth, as reported by MarketBeat.

Tucows presently has a consensus target price of $70.00, indicating a potential downside of 12.07%. Given Tucows' higher probable upside, equities analysts plainly believe Tucows is more favorable than NantHealth.

Summary

Tucows beats NantHealth on 9 of the 12 factors compared between the two stocks.

Sohu.com (NASDAQ:SOHU) and NantHealth (NASDAQ:NH) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

Institutional & Insider Ownership

39.4% of Sohu.com shares are owned by institutional investors. Comparatively, 5.5% of NantHealth shares are owned by institutional investors. 21.1% of Sohu.com shares are owned by company insiders. Comparatively, 59.6% of NantHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Sohu.com and NantHealth's net margins, return on equity and return on assets.

Risk and Volatility

Sohu.com has a beta of 2.13, suggesting that its stock price is 113% more volatile than the S&P 500. Comparatively, NantHealth has a beta of 1.83, suggesting that its stock price is 83% more volatile than the S&P 500.

Valuation & Earnings

This table compares Sohu.com and NantHealth's revenue, earnings per share and valuation.

NantHealth has lower revenue, but higher earnings than Sohu.com. Sohu.com is trading at a lower price-to-earnings ratio than NantHealth, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current ratings for Sohu.com and NantHealth, as reported by MarketBeat.

Sohu.com presently has a consensus target price of $26.6667, indicating a potential upside of 50.07%. Given Sohu.com's higher probable upside, equities analysts plainly believe Sohu.com is more favorable than NantHealth.

Summary

Sohu.com beats NantHealth on 8 of the 13 factors compared between the two stocks.

Veritone (NASDAQ:VERI) and NantHealth (NASDAQ:NH) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

Analyst Recommendations

This is a breakdown of current ratings for Veritone and NantHealth, as reported by MarketBeat.

Veritone presently has a consensus target price of $30.1667, indicating a potential upside of 64.22%. Given Veritone's higher probable upside, equities analysts plainly believe Veritone is more favorable than NantHealth.

Risk and Volatility

Veritone has a beta of 3.55, suggesting that its stock price is 255% more volatile than the S&P 500. Comparatively, NantHealth has a beta of 1.83, suggesting that its stock price is 83% more volatile than the S&P 500.

Profitability

This table compares Veritone and NantHealth's net margins, return on equity and return on assets.

Institutional & Insider Ownership

28.1% of Veritone shares are owned by institutional investors. Comparatively, 5.5% of NantHealth shares are owned by institutional investors. 25.6% of Veritone shares are owned by company insiders. Comparatively, 59.6% of NantHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Veritone and NantHealth's revenue, earnings per share and valuation.

Veritone has higher earnings, but lower revenue than NantHealth. Veritone is trading at a lower price-to-earnings ratio than NantHealth, indicating that it is currently the more affordable of the two stocks.

Summary

NantHealth beats Veritone on 7 of the 13 factors compared between the two stocks.

NantHealth (NASDAQ:NH) and Brightcove (NASDAQ:BCOV) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

Analyst Ratings

This is a breakdown of current recommendations and price targets for NantHealth and Brightcove, as reported by MarketBeat.com.

Brightcove has a consensus target price of $21.25, suggesting a potential upside of 56.83%. Given Brightcove's higher probable upside, analysts clearly believe Brightcove is more favorable than NantHealth.

Risk and Volatility

NantHealth has a beta of 1.83, suggesting that its share price is 83% more volatile than the S&P 500. Comparatively, Brightcove has a beta of 0.91, suggesting that its share price is 9% less volatile than the S&P 500.

Profitability

This table compares NantHealth and Brightcove's net margins, return on equity and return on assets.

Institutional and Insider Ownership

5.5% of NantHealth shares are held by institutional investors. Comparatively, 84.5% of Brightcove shares are held by institutional investors. 59.6% of NantHealth shares are held by company insiders. Comparatively, 2.3% of Brightcove shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Earnings and Valuation

This table compares NantHealth and Brightcove's top-line revenue, earnings per share and valuation.

Brightcove has higher revenue and earnings than NantHealth. Brightcove is trading at a lower price-to-earnings ratio than NantHealth, indicating that it is currently the more affordable of the two stocks.

Summary

Brightcove beats NantHealth on 9 of the 13 factors compared between the two stocks.